Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anixa Biosciences Inc.

    NASDAQ: ANIX · Real-Time Price · USD
    2.77
    -0.07 (-2.32%)
    At close: Jun 06, 2025, 3:59 PM
    2.86
    3.25%
    After-hours: Jun 06, 2025, 05:30 PM EDT

    Anixa Biosciences Statistics

    Share Statistics

    Anixa Biosciences has 32.21M shares outstanding. The number of shares has increased by 0.59% in one year.

    Shares Outstanding

    n/a
    		 32.21M

    Shares Change (YoY)

    n/a
    		 0.59%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 18.32%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 13

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 377.41K, so 1.17% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 377.41K

    Short % of Shares Out

    n/a
    		 1.17%

    Short % of Float

    n/a
    		 1.2%

    Short Ratio (days to cover)

    n/a
    		 10.06

    Valuation Ratios

    The PE ratio is -8.89 and the forward PE ratio is -7.69. Anixa Biosciences's PEG ratio is -0.41.

    PE Ratio

    n/a
    		 -8.89

    Forward PE

    n/a
    		 -7.69

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 4

    PB Ratio

    n/a
    		 5.58

    P/FCF Ratio

    n/a
    		 -15.22

    PEG Ratio

    n/a
    		 -0.41
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Anixa Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.54, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 8.54

    Quick Ratio

    n/a
    		 8.54

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,510,800

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 144K

    Effective Tax Rate

    n/a
    		 -1.15%

    Stock Price Statistics

    The stock price has increased by 19.92% in the last 52 weeks. The beta is 0.33, so Anixa Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.33

    52-Week Price Change

    n/a
    		 19.92%

    50-Day Moving Average

    n/a
    		 2.7

    200-Day Moving Average

    n/a
    		 2.96

    Relative Strength Index (RSI)

    n/a
    		 58.39

    Average Volume (20 Days)

    n/a
    		 55,671

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -13.83M

    Net Income

    n/a
    		 -12.55M

    EBITDA

    n/a
    		 -12.66M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.39
    Full Income Statement

    Balance Sheet

    The company has 1.27M in cash and 232K in debt, giving a net cash position of 1.04M.

    Cash & Cash Equivalents

    n/a
    		 1.27M

    Total Debt

    n/a
    		 232K

    Net Cash

    n/a
    		 1.04M

    Retained Earnings

    n/a
    		 -240.75M

    Total Assets

    n/a
    		 18.91M

    Working Capital

    n/a
    		 16.69M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.33M and capital expenditures 0, giving a free cash flow of -7.33M.

    Operating Cash Flow

    n/a
    		 -7.33M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -7.33M

    FCF Per Share

    n/a
    		 -0.23
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ANIX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANIX is $10, which is 253.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 253.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 26, 2015. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Jun 26, 2015

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 2.99

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist